Dr Lal PathLabs announced key financial outcomes following its Board Meeting on November 04, 2026. The company declared a 2nd interim dividend of INR 5 per equity share for the financial year 2026-27, with a record date of November 11, 2026. Additionally, the Board approved a further investment of up to INR 49.5 Crores in its wholly-owned subsidiary, LPL Dubai, for business and operational requirements.
Dr Lal PathLabs Board Meeting Outcomes
In a significant board meeting held on November 04, 2026, Dr Lal PathLabs Limited announced several key financial and strategic decisions. The Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2026, along with the limited review report.
Interim Dividend Declaration
A major highlight was the declaration of the 2nd interim dividend for the financial year 2026-27. Shareholders will receive INR 5 per equity share, representing a 50% payout on the face value of INR 10 per share. The record date for this dividend payment has been set for November 11, 2026, and the dividend will be paid within 30 days of its declaration.
Director Appointment
The Board also approved the appointment of Ms. Vasuta Agarwal (DIN: 07480674) as an Additional Director, designated as a Non-Executive Independent Director. This appointment is for a term of three consecutive years, commencing November 04, 2026, and is subject to member approval via postal ballot. Ms. Agarwal is a seasoned business and technology leader with extensive experience in artificial intelligence, digital advertising, and business operations.
Strategic Investment in Subsidiaries
Further strengthening its global operations, the company approved an investment of up to INR 49.5 Crores in its wholly-owned subsidiary, Dr. Lal PathLabs FZCO (“LPL Dubai”). This investment, to be made in one or more tranches, is intended to meet LPL Dubai’s business and operational requirements, including further investment in its subsidiary, Sunshine Healthcare Limited (“SHL”), Ghana. The transaction is expected to be completed by March 31, 2027.
Financial Highlights
The unaudited consolidated financial results for the quarter ended September 30, 2026, show total income of INR 9,082 million and a profit after tax of INR 1,939 million. For the half-year ended September 30, 2026, total income stood at INR 17,378 million with a profit after tax of INR 3,644 million.
Source: BSE
